Both in Pharmaceuticals
Xenetic Biosciences vs Imunon
Over the past year XBIO returned −41.3% and IMNN returned −82.3%; their daily moves had a correlation of 0.06.
XBIO −41.3% IMNN −82.3%Growth of $1, one year, split-adjusted
| Metric | XBIO | IMNN |
|---|---|---|
| Price | $2.10 | $0.8301 |
| Market cap | $4.9M | $4.7M |
| Today | +15.09% | −5.26% |
| 1 month | −7.1% | −37.8% |
| 6 months | −30.0% | −69.0% |
| Year to date | −3.2% | −78.2% |
| 1 year | −44.0% | −82.4% |
| Revenue growth (YoY) | +12.0% | — |
| Gross margin | 100.0% | — |
| Net margin | −140.7% | — |
| P/E (TTM) | — | — |
| Price / sales | 3.4× | — |
| Net cash | $6.5M | -$169.7K |
| Dividend yield | — | — |
| Volatility (60d) | 160.8% | 91.5% |
| Short % of float | 0.5% | 1.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).